Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lercanidipine 20 mg vs ZANIDIP 20 mg in healthy Thai volunteers (fasting)
TCTR20230914003Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lercanidipine in hypertension (HTN) (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
lercanidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20230914003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230914003.